Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer

Gram-positive bacterial infections are an important cause of morbidity and death among cancer patients, despite current therapy. In this case-control study, we evaluated the clinical outcomes and safety of telavancin in cancer patients with uncomplicated Gram-positive bloodstream infections (BSIs)....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Chaftari, Anne-Marie, Hachem, Ray, Jordan, Mary, Garoge, Kumait, Al Hamal, Zainab, El Zakhem, Aline, Viola, George M., Granwehr, Bruno, Mulanovich, Victor, Gagel, Andrew, Reitzel, Ruth, Yousif, Ammar, Jiang, Ying, Raad, Issam
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2015
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4704239/
https://ncbi.nlm.nih.gov/pubmed/26482312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00617-15
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados